BLOCKADE OF COCAINE-INDUCED CONDITIONED PLACE PREFERENCE - RELEVANCE TO COCAINE ABUSE THERAPEUTICS

被引:54
作者
CALCAGNETTI, DJ [1 ]
KECK, BJ [1 ]
QUATRELLA, LA [1 ]
SCHECHTER, MD [1 ]
机构
[1] NE OHIO UNIV,COLL MED,DEPT PHARMACOL,ROOTSTOWN,OH 44272
关键词
BUPRENORPHINE; COCAINE; CONDITIONED PLACE PREFERENCE; ELECTRICAL BRAIN STIMULATION; ICS205-930; ISRADIPINE; NALTRINDOLE; NIFEDIPINE MDL72222; SELF ADMINISTRATION; STIMULUS DISCRIMINATION;
D O I
10.1016/0024-3205(94)00414-N
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Conditioned place preference/aversion testing is a behavioral method believed capable of measuring the affective (positive, neutral or negative) properties of psychoactive drugs. Cocaine injections in rats reliably produces a positive place preference. Drugs that attenuate or block this effect of cocaine have obvious potential for developing treatments to address cocaine addiction as well as to add to the scientific understanding of the mechanism of cocaine's action at the cellular level. To date, six drugs have been reported to block the expression of a cocaine-induced conditioned place preference (CPP) and this review evidences the cocaine-induced CPP blockage by the two potent L-type calcium channel blockers, isradipine and nifedipine, the two serotonin-3 receptor antagonists, MDL72222 and ICS205-930, the delta opioid receptor selective antagonist naltrindole, and lastly, a mixed opioid agonist-antagonist buprenorphine. Additional evidence relating to the blockade of other cocaine behavioral effects by these putative blockers is addressed, where appropriate, from studies employing other procedures such as drug stimulus discrimination, self-administration, electrical brain stimulation and increases in locomotor activity. The significance of these findings is discussed in the context of their relevance to the development of treatment regimens to allow for cessation of cocaine abuse.
引用
收藏
页码:475 / 483
页数:9
相关论文
共 80 条
[1]   BLOCKADE OF ACQUISITION OF DRUG-CONDITIONED PLACE AVERSION BY 5HT3 ANTAGONISTS [J].
ACQUAS, E ;
CARBONI, E ;
GARAU, L ;
DICHIARA, G .
PSYCHOPHARMACOLOGY, 1990, 100 (04) :459-463
[2]   BLOCKADE OF DELTA-OPIOID RECEPTORS IN THE NUCLEUS-ACCUMBENS PREVENTS ETHANOL-INDUCED STIMULATION OF DOPAMINE RELEASE [J].
ACQUAS, E ;
MELONI, M ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (02) :239-241
[3]  
ARAKAWA K, 1993, TRANSPLANT P, V25, P738
[4]   NALOXONE ATTENUATION OF THE EFFECT OF COCAINE ON REWARDING BRAIN-STIMULATION [J].
BAIN, GT ;
KORNETSKY, C .
LIFE SCIENCES, 1987, 40 (11) :1119-1125
[5]   MDL72222, A SEROTONIN 5-HT3 RECEPTOR ANTAGONIST, BLOCKS MDMAS ABILITY TO ESTABLISH A CONDITIONED PLACE PREFERENCE [J].
BILSKY, EJ ;
REID, LD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (02) :509-512
[6]  
BILSKY EJ, 1992, LIFE SCI, V50, pL85
[7]  
BROWN EE, 1991, J PHARMACOL EXP THER, V256, P119
[8]   DELTA-OPIOID ANTAGONIST, NALTRINDOLE, SELECTIVELY BLOCKS ANALGESIA INDUCED BY DPDPE BUT NOT DAGO OR MORPHINE [J].
CALCAGNETTI, DJ ;
HOLTZMAN, SG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (01) :185-190
[9]   ANALGESIA PRODUCED BY CENTRALLY ADMINISTERED DAGO, DPDPE AND U50488H IN THE FORMALIN TEST [J].
CALCAGNETTI, DJ ;
HELMSTETTER, FJ ;
FANSELOW, MS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 153 (01) :117-122
[10]   ISRADIPINE PRODUCES NEITHER A CONDITIONED PLACE PREFERENCE NOR AVERSION [J].
CALCAGNETTI, DJ ;
SCHECHTER, MD .
LIFE SCIENCES, 1994, 54 (06) :PL81-PL86